Education
About Us
Working with TipRanks
Follow Us
Mindbio Therapeutics Corp. (TSE:MBIO)
:MBIO
RESEARCH TOOLSreports
MBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.04
Previous CloseN/A
Volume53.00K
Average Volume (3M)148.13K
Market Cap
N/A
Enterprise ValueC$6.18M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.03
Next Earnings
Nov 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding546,197,750
10 Day Avg. Volume219,588
30 Day Avg. Volume148,127
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mindbio Therapeutics Corp. News
MBIO FAQ
What was Mindbio Therapeutics Corp.’s price range in the past 12 months?
Mindbio Therapeutics Corp. lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Mindbio Therapeutics Corp.’s market cap?
Currently, no data Available
When is Mindbio Therapeutics Corp.’s upcoming earnings report date?
Mindbio Therapeutics Corp.’s upcoming earnings report date is Nov 03, 2025 which is in 82 days.
How were Mindbio Therapeutics Corp.’s earnings last quarter?
Currently, no data Available
Is Mindbio Therapeutics Corp. overvalued?
According to Wall Street analysts Mindbio Therapeutics Corp.’s price is currently Overvalued.
Does Mindbio Therapeutics Corp. pay dividends?
Mindbio Therapeutics Corp. does not currently pay dividends.
What is Mindbio Therapeutics Corp.’s EPS estimate?
Mindbio Therapeutics Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mindbio Therapeutics Corp. have?
Mindbio Therapeutics Corp. has 546,197,750 shares outstanding.
What happened to Mindbio Therapeutics Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mindbio Therapeutics Corp.?
Currently, no hedge funds are holding shares in TSE:MBIO
Company Description
Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. operates as a clinical stage drug development company. It is involved in the clinical research into the microdosing of psychedelic medicines to treat a range of medical conditions, such as depression, anxiety, PTSD, panic disorder, chronic pain, and opiate addictions. The company is based in Melbourne, Australia.
Mindbio Therapeutics Corp. (MBIO) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Wesana Health Holdings Inc
―
Braxia Scientific
―
HAVN Life Sciences
―
Lexston Life Sciences Corp.
―
Awakn Life Sciences
―
Ownership Overview
18.21% Insiders
―
Mutual Funds
― Other Institutional Investors
81.79% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---